Holistic Recovery from Schizophrenia: After her Brain Broke — I’m a mother, too, and I may not be wild about people hinting that maybe I should take a look at myself, but what I cannot understand is someone who isn’t intellectually curious and fearless enough to be willing to investigate the possibility if it could result in breakthroughs for her daughter. Susan Inman refuses to go down that path. She paints an idyllic but sketchy portrait of family life. How many of us are that fine and noble as parents? I am ashamed of things I have said and done in moments of anger when the children were small. Chris’s childhood was normal enough, but mental illness is a lot more nuanced that what is on the surface. People on the outside looking in might think that ours was a normal family, and it was, but it isn’t really. No family is normal. None. What is so hard about that? — Yes Rossa! It’s not about blaming to acknowledge that every human being deals with dysfunction! And it’s part of what makes us.
Anis Shivani: The Mass Production of Mental Illness and What To Do About It — I would say we already have lots of answers that are being ignored and need to be rediscovered and applied, as well as the following… “Conventional psychiatry, which reached its zenith with the neo-Kraepelinian movement, has not only failed to deliver tangible benefits for patients (antipsychotics…were an accidental discovery) but has also failed to deliver a credible explanation of psychosis. It is not that there is a lack of biological evidence; rather, the evidence has been misinterpreted and shoehorned into a biomedical framework that fits it poorly. A radical new approach to understanding severe mental illness, which brings together the evidence on the social, psychological and biological causes of psychosis, is urgently required.”
NAMI State Chapters And Pharma Funding // Pharmalot — How does Pharma influence NAMI? Who is NAMI really advocating for? — The latest chapter in the saga involving the National Alliance on Mental Illness, or NAMI, and the amount of money accepted from the pharmaceutical industry has millions being contributed to NAMI state chapters. And Chuck Grassley, the ranking Republican on the Senate Finance Committee, who has been probing the relationship between patient groups and drugmakers and how this may influence the practice of medicine, wants to know what the national organization is doing to make the state chapters more transparent, and how the money is used.